United States · 
Who invested in Chroma Medicine?
Chroma Medicine's investors include DCVC, ARCH Venture Partners, Wellington Management, Janus Henderson Investors and Cormorant Asset Management.
United States · Series B startup
Who invested in Chroma Medicine
Funding summaryUpdated 26 Oct 2026
$135Mraised across 1 round since 2023, from 1 source
- Latest round
- Series B, $135MFeb 2023
- Investors
- 5
The rounds
- Feb 2023Series B$135M
Source recordedSEC filing: $135M sold, first sale Feb 2023
Founders and team
From Chroma Medicine's own website and the SEC filings it signed: 5 on the team.
- Jeffrey WalshChief Executive Officer
- Lisa McGrathChief People Officer
- Brett KaplanExecutive Officeri
- Catherine Stehman-BreenExecutive Officer, Directori
- Vic MyerExecutive Officeri
On the board, as filediBihua ChenGeorge GolumbeskiJeff MarrazzoKevin BittermanMichael KellyPaola PozziThomas Cahill
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Chroma Medicine
How much has Chroma Medicine raised?
Chroma Medicine has raised $135M across 1 round since 2023.
When did Chroma Medicine last raise?
Chroma Medicine's most recent round was a Series B of $135M in Feb 2023.
What was Chroma Medicine's biggest round?
Its most recent round, $135M in Feb 2023, is also its largest on record.
Who backed Chroma Medicine first?
Chroma Medicine's first round on record, in Feb 2023, was backed by DCVC, ARCH Venture Partners and Wellington Management and 2 others.
What stage is Chroma Medicine at?
Chroma Medicine's latest named round is a Series B, in Feb 2023.
Where is Chroma Medicine based?
Chroma Medicine is based in the United States.
Companies like Chroma Medicine
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.